“Global Immunochemistry Reagents, Analyzers and Test Kits market set to grow to $34bn by 2024” says Visiongain report

01 October 2019
Pharma

Visiongain has launched a new pharma report Global Immunochemistry Reagents, Analyzers and Test Kits Market 2019-2029: Reagents and Test Kits, Analyzers, Disease Specific Tests, Rapid Tests, Drugs of Abuse/Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anemia/Vitamin Tests, Allergic Blood Tests, Autoimmune Diseases, Cardiac Markers, Infectious Diseases, Tumor Markers, Chemiluminescence Analyzers, ELISA Analyzers, Immunofluorescence Analyzers, Radioimmunoassay Analyzers.

Immunochemistry technologies have evolved significantly over the years and now offer critical testing in all areas. High incidences of cancer, infectious diseases and cardiovascular diseases globally will fuel the demand for better disease specific immunochemistry tests.

The lead analyst of the report commented "Established markets such as the US and Western Europe dominate the global immunochemistry market. However, these markets are restrained by reduced healthcare budgets and increased regulatory pressures on device development and approval, which now requires evidence of clinical cost-effectiveness before approval is given.

There is therefore more opportunity for market penetration and larger sales volumes in emerging countries, such as India and China, as these countries remain relatively under penetrated and their diagnostic testing markets offer huge opportunities, especially with the vast population pool."

Leading companies featured in the report include Abbott, bioMerieux, Danaher, Fujirebio, Ortho Clinical Diagnostics, Roche, Siemens, Sysmex Corporation, Thermo Fisher Scientific, Trivitron Healthcare Pvt. Ltd. and other companies.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever